Drug resistance is a major obstacle in cancer treatment–leading to relapse for many patients. In a new study, published online April 20, 2020, in Nature Cell Biology, researchers from the Stowers Institute for Medical Research, Children’s Mercy Hospital Kansas City, and The University of Kansas Cancer Center report on a promising new strategy to overcome drug resistance in leukemia, using targeted doses of the widely-used chemotherapy drug doxorubicin.
- Vermont’s BIPOC drivers are most likely to have a run-in with police, study shows
- Many parents say teens with anxiety, depression may benefit from peer confidants at school
- Where COVID-19 hit hardest, sudden deaths outside the hospital increased
- Scientists shed light on how and why some people report “hearing the dead”
- Changing diets — not less physical activity — may best explain childhood obesity crisis